Health Care & Life Sciences » Biotechnology | BBI Life Sciences Corp.

BBI Life Sciences Corp. | Income Statement

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
277,562.90
318,650.90
348,322.60
411,313.70
533,190.80
688,878.40
Cost of Goods Sold (COGS) incl. D&A
141,872.60
159,990.60
167,496.80
203,353.90
275,910.60
362,567.30
Gross Income
135,690.20
158,660.30
180,825.80
207,959.80
257,280.20
326,311.10
SG&A Expense
76,800.80
107,181.40
112,851.10
133,108.60
180,069.50
227,386.70
EBIT
57,046.10
51,475.10
67,995.60
74,851.20
78,147.00
98,982.40
Unusual Expense
-
29,355.20
-
-
-
829.10
Non Operating Income/Expense
788.60
30,175.80
3,284.80
1,971.10
4,629.60
4,891.80
Interest Expense
1,003.10
-
-
-
735.70
1,231.80
Pretax Income
56,618.30
57,312.20
70,993.00
84,489.50
83,119.10
104,426.20
Income Tax
9,121.00
14,215.10
8,889.70
13,496.40
11,362.50
13,601.10
Equity in Affiliates
5,932.60
2,182.30
-
1,947.80
1,103.50
870.60
Consolidated Net Income
53,430.00
45,279.40
62,103.30
69,045.40
70,653.10
89,954.50
Net Income
50,782.90
41,896.40
62,098.40
70,318.90
74,311.80
93,695
Net Income After Extraordinaries
50,782.90
41,896.40
62,098.40
70,318.90
74,311.80
93,695
Net Income Available to Common
50,782.90
41,896.40
62,098.40
70,318.90
74,311.80
93,695
EPS (Basic)
0.10
0.11
0.12
0.13
0.14
0.17
Basic Shares Outstanding
524,663.10
394,216.00
530,647.00
542,654.00
544,414.00
546,778
EPS (Diluted)
0.10
0.11
0.11
0.13
0.14
0.17
Diluted Shares Outstanding
524,663.10
394,265.00
542,874.00
543,512.00
548,704.00
550,743
EBITDA
71,065.00
67,911.50
87,237.90
96,252.00
106,429.90
133,471.40
Other Operating Expense
1,843.40
3.80
21.00
-
936.30
58
Non-Operating Interest Income
1,363.90
3,974.40
5,682.60
7,313.10
1,078.10
2,612.90
Minority Interest Expense
2,647.10
3,382.90
4.90
1,273.60
3,658.70
3,740.50

About BBI Life Sciences

View Profile
Address
No. 698, Xiangmin Road
Shanghai Shanghai 201611
China
Employees -
Website http://www.bbi-lifesciences.com
Updated 07/08/2019
BBI Life Sciences Corp. is an investment holding company that engages in the development, manufacture, and sale of various life sciences products used in scientific research. The firm also provides life sciences related services. It operates through the following segments: DNA Synthesis Products, Genetic Engineering Services, Life Sciences Research Consumables, and Protein and Antibody Related Products and Services.